Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of generic entecavir
monotherapy or in combination with adefovir for chronic hepatitis B patients with inadequate
response to NUC therapy